Literature DB >> 33432954

Caffeic acid protects against Aβ toxicity and prolongs lifespan in Caenorhabditis elegans models.

Hui Li1, Xiaoxuan Yu1, Chenxi Li1, Lei Ma2, Zhenyu Zhao2, Shuwen Guan3, Liping Wang3.   

Abstract

Caffeic acid (CA), a derivative of cinnamic acid, exists in various vegetables and fruits. Natural compounds as beneficial antioxidants play an important role in the research of Alzheimer's disease (AD). In this study, we evaluated the effects of CA against AD using the C. elegans models of AD. We found that CA significantly alleviated Aβ-induced toxicity, increased lifespan, decreased body paralysis, and improved reproductive defects. Also, CA treatment increased resistance to heat and oxidative stress in N2 and CL4176. Moreover, reactive oxygen species (ROS) levels and polyglutamine (polyQ40) aggregate formation were reduced. Furthermore, the mechanistic studies revealed that CA activated transcription factor DAF-16 and its downstream targets SOD-3 and GST-4 to protect against Aβ toxicity. Also, the heat shock proteins hsf-1 and hsp-16.2 mRNA were up-regulated in CL4176. Moreover, CA activated the mRNA expression of lgg-1. Lastly, the KEGG (Kyoto Encyclopedia of Genes and Genomes) analysis of RNA-seq data revealed that there was a significant change in the metabolism-related pathways. Overall, these results suggested an underlying mechanism of action of CA in treating AD at an organism level.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33432954     DOI: 10.1039/d0fo02784g

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  5 in total

1.  Neuroprotective Effects of Oligosaccharides in Rehmanniae Radix on Transgenic Caenorhabditis elegans Models for Alzheimer's Disease.

Authors:  Nianxin Kang; Yage Luan; Yu Jiang; Wenhao Cheng; Yongjian Liu; Zhijun Su; Yonggang Liu; Peng Tan
Journal:  Front Pharmacol       Date:  2022-06-17       Impact factor: 5.988

Review 2.  Natural Bioactive Products and Alzheimer's Disease Pathology: Lessons from Caenorhabditis elegans Transgenic Models.

Authors:  María D Navarro-Hortal; Jose M Romero-Márquez; Safa Osta; Victoria Jiménez-Trigo; Pedro Muñoz-Ollero; Alfonso Varela-López
Journal:  Diseases       Date:  2022-05-13

3.  Diterpenoid Caesalmin C Delays Aβ-Induced Paralysis Symptoms via the DAF-16 Pathway in Caenorhabditis elegans.

Authors:  Zong-Ping Zhang; Xue Bai; Wen-Bo Cui; Xiao-Han Chen; Xu Liu; De-Juan Zhi; Zhan-Xin Zhang; Dong-Qing Fei; Dong-Sheng Wang
Journal:  Int J Mol Sci       Date:  2022-06-20       Impact factor: 6.208

Review 4.  Modeling Alzheimer's Disease in Caenorhabditis elegans.

Authors:  Javier Alvarez; Pilar Alvarez-Illera; Jaime Santo-Domingo; Rosalba I Fonteriz; Mayte Montero
Journal:  Biomedicines       Date:  2022-01-26

5.  Cryptotanshinone Alleviates Oxidative Stress and Reduces the Level of Abnormally Aggregated Protein in Caenorhabditis elegans AD Models.

Authors:  Wen-Bo Cui; Zong-Ping Zhang; Xue Bai; Shan-Shan Wang; Xiao-Han Chen; Xu Liu; Pan-Jie Su; De-Juan Zhi; Dong-Qing Fei; Zhan-Xin Zhang; Dong-Sheng Wang
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.